首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and biological evaluation of a novel human stem/progenitor cells proliferation activator: 4-(4-(5-mercapto-1,3,4-oxadiazol-2-yl)phenyl) thiosemicarbazide (Stemazole).
【24h】

Synthesis and biological evaluation of a novel human stem/progenitor cells proliferation activator: 4-(4-(5-mercapto-1,3,4-oxadiazol-2-yl)phenyl) thiosemicarbazide (Stemazole).

机译:新型人类干/祖细胞增殖活化剂:4-(4-(5-巯基-1,3,4-恶二唑-2-基)苯基)硫代氨基脲(Stemazole)的合成和生物学评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Stem/progenitor cells are crucial for cell-based therapy and regenerative medicine, and their application in clinical and basic research requires a large supply of cells. To identify effective stem/progenitor cell proliferation activators, we synthesised a series of new 4-(4-(5-mercapto-1,3,4-oxadiazol-2-yl)phenyl) thiosemicarbazide (named Stemazole) derivatives. Preliminary evaluation of the structure-activity relationship (SAR) and the biological activities of the compounds were determined with a luminescent cell viability assay. The identified leading compound, Stemazole, exhibited remarkable proliferation-promoting activity in human hippocampal stem/progenitor cells (HSCs) in a time-dependent and concentration-dependent manner. The proliferation-promoting activity of Stemazole was further confirmed against a panel of human stem/progenitor cells derived from each of the three blastoderm layers. In conclusion, Stemazole is a novel activator of stem cells proliferation.
机译:干细胞/祖细胞对于基于细胞的治疗和再生医学至关重要,它们在临床和基础研究中的应用需要大量的细胞供应。为了鉴定有效的干/祖细胞增殖活化剂,我们合成了一系列新的4-(4-(5-巯基-1,3,4-恶二唑-2-基)苯基)硫代氨基脲(命名为Stemazole)衍生物。通过发光细胞生存力测定法确定了化合物的结构活性关系(SAR)和生物活性的初步评估。鉴定出的领先化合物Stemazole在人类海马干/祖细胞(HSC)中以时间依赖性和浓度依赖性的方式表现出显着的增殖促进活性。进一步证实了对异源于三个胚层的每组人类干/祖细胞的Stemazole的增殖促进活性。总之,Stemazole是干细胞增殖的新型激活剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号